Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Late-Stage Cell Therapy: Key Challenges and the CDMO Advantage
https://www.contractpharma.com/late-stage-cell-therapy-key-challenges-and-the-cdmo-advantage/
The Future of Chocolate is Cultivated: Pluri’s Vision with Kokomodo
https://nuffoodsspectrum.asia/2025/06/13/the-future-of-chocolate-is-cultivated-pluris-vision-with-kokomodo.html
Alliance Global Partners has initiated coverage on Pluri with a "Buy" rating and a price target of $12.00 USD for the stock.
https://www.gurufocus.com/news/2902070/alliance-global-partners-initiates-coverage-on-pluri-plur-with-a-buy-rating-plur-stock-news
8K Out
On May 21, 2025, the Board of Directors of Pauri Inc. (the “Company”) approved the rescheduling of the Company’s 2025 Annual Meeting of Shareholders (the “2025 Annual Meeting”) to be held on Monday, June 30, 2025, at 4:00 p.m. Israel time, at the Company’s office located at MATAM Advanced Technology Park Building No. 5, Haifa, Israel 3508409, instead of May 23, 2025 as previously disclosed. The record date for the determination of shareholders of the Company entitled to receive notice of and to vote at the 2025 Annual Meeting has been re-set as the close of business on May 23, 2025.
Wednesday May 21st A.G.P.’s Annual Healthcare Company Showcase!
Yaky Yanay, CEO and President of Pluri, will be presenting at A.G.P./Alliance Global Partners’ Annual Healthcare Company Showcase tomorrow between 8:00 – 8:20 AM ET
https://us02web.zoom.us/webinar/register/WN_jB1HgKLvQFmUfC6VBT11mw#/registration
"We anticipate that the coming fiscal year will mark a significant turning point..."
I'm reasonably certain that we were told the same thing in an update from a few years ago.
Pluri CEO Issues Shareholder Letter Highlighting Strategic Growth, Innovation, and Global Market Expansion
https://pluri-biotech.com/releases/pluri-ceo-issues-shareholder-letter-highlighting-strategic-growth-innovation-and-global-market-expansion/
Unlocking the Potential of Unconventional T Cells” by our VP Clinical Development Dr. Michal Sheleg was featured in Cell & Gene Therapy Review. It explores how these unique cells could transform treatment for solid tumors.
https://www.nxtbook.com/comparenetworks/CellGeneTherapyReview/cell-gene-therapy-review-q2-2025/index.php#/p/22
The industry, according to Herman, is keeping a close eye on the development of Coffeesai’s technology. He says he is already in discussion with many of the world’s biggest coffee companies, which are eagerly looking for solutions as coffee prices continue to rise.
“We have a long waiting list of companies that are fascinated with what we are doing. I get calls every day asking to visit us to taste the product. We are already in negotiations with many of the biggest names in the industry,” he says.
https://www.gcrmag.com/is-lab-grown-coffee-the-future-of-the-industry/
On May 7, 2025, the Company received a letter from Nasdaq, determining that the Company has regained compliance with Listing Rule 5550(b)(2), due to the fact that for the 10 consecutive business days from April 22, 2025 through May 6, 2025, the market value of the Company’s listed securities was $35 million or greater, satisfying the requirement under Rule 5550(b)(2). As a result, this matter is now closed, and the Company remains in good standing on The Nasdaq Capital Market.
Q&A with Alejandro Weinstein, Pluri Board of Directors
https://www.citybiz.co/article/690836/qa-with-alejandro-weinstein-pluri-board-of-directors/
May Company Presentation !!!
https://pluri-biotech.com/presentation/
You can't make this sh*t up!
From 3 to 7 to under 5 in less than a week.
This isn't a company, its a rigged casino.
Pluri Completes Strategic Acquisition of Leading Cultivated Cacao AgFoodTech Company, Kokomodo Ltd.
https://pluri-biotech.com/releases/pluri-completes-strategic-acquisition-of-leading-cultivated-cacao-agfoodtech-company-kokomodo-ltd/
Not even a week! Lol
Not sure if that's true. In any case , whoever it is, in a week, they will be sorry.
Welcome new bagholders.
Yesterday's price action suggests to me that some big player or insider decided to jump in and pay over a million dollars to buy a couple hundred thousand shares. The big questions are who and why?
I've always chalked up the failure more to incompetence than dishonesty. That doesn't necessarily make me feel any better. Is it better to support a bunch of idiots or a bunch of crooks?
8 years in for me, Jaime. Like you, I've basically given up and consider this lost money. Where we differ, I believe, is in our view of the company. I consider them a criminal enterprise just looking to scam unsuspecting investors with fraudulent promises of cutting edge solutions when they don't have any intention of following through on.
Sekander, I'm in no position to disagree with you. I've owned Plur for more than 7 years, and it's been one disappointment after another.
The good news is that a couple of years ago, I conceded that I would likely lose my entire Plur investment. So, if ANYTHING positive happens, I'll consider it a psychological windfall.
I've been barely paying attention the last couple years, but the sudden upward price movement of last week caught my attention. I'll keep watching- for a little while.
OK, kids, party's over.
We made enough to keep us in the chips for another couple of years. Time to drop it back down again.
Utah flouts FDA with law greenlighting placental stem cell therapies
https://www.science.org/content/article/utah-flouts-fda-law-greenlighting-placental-stem-cell-therapies
Its all fabricated BS. They have no product and no prospects
other than the usual, "yeah, we're working on that."
Make believe company looking for more suckers.
It's been a while since they used the share offering trick so they
must think they can pull it off again. Absolutely no reason for this
stock to go up in a normal world.
If we could have gotten to $7.24 per share, we would have had a 100% increase since the April 16 close.
Must be another share offering coming. Time for artificial inflation to make it look appealing.
They must be running out of suckers.
Only $84 a share to go before I'm even. that's what 2 reverse splits in 7 years will do to your
investment.
We spoke with Arik Avni, head of the radiation department at Pluri, a biomedical engineering company specializing in cellular therapy
https://www.israelhayom.com/2025/04/23/healthcare-collapse-inevitable-after-nuclear-strike/
What's the deal, here? Big gain day. Did they finally fire Yaki?
In case of a nuclear event, Ukraine to use Israeli placenta-based emergency treatment
https://www.msn.com/en-us/health/medical/in-case-of-a-nuclear-event-ukraine-to-use-israeli-placenta-based-emergency-treatment/ar-AA1DgA0P?ocid=BingNewsSerp
Pluri Announces Expansion of Intellectual Property Portfolio with Two Granted Patents for 3D Expansion of Immune Cells in the United States and Israel
https://pluri-biotech.com/releases/pluri-announces-expansion-of-intellectual-property-portfolio-with-two-granted-patents-for-3d-expansion-of-immune-cells-in-the-united-states-and-israel/
Pluri CEO Yaky Yanay on pioneering cell-tech solutions for global needs
April Company Presentation !!!
https://pluri-biotech.com/presentation/
Going to thoroughly enjoy watching this giant scam come to an end. New all time lows daily now, but with negative shareholder equity, $500,000,000.00 spent with literally nothing to show for it, is well deserved. Only thing more deserved is for management to be in jail where they belong.
New all time lows. Only a matter of time now before the scammers are done scamming.
Rethinking bioreactors: Ever After Foods and Bühler aim to lower cultivated meat costs
https://www.foodnavigator-usa.com/Article/2025/04/01/ever-after-foods-and-buhler-aim-to-lower-cultivated-meat-costs/
They’ve burned through half a billion dollars worth of cash already, so they’re gifting themselves pretty much the only thing that’s left, shares. Greedy right until the bitter end.
If You Look At Page 32 In Today's SEC Filing, You Will See that Technically, Insiders Now Own 90.2 % Of All Outstanding Shares !!! Leaving Less Than 10% Outstanding !!!
That Is Incredible !!!
Shareholder Meeting Notice is Out !!!
https://www.sec.gov/ix?doc=/Archives/edgar/data/1158780/000101376225000302/ea0234240-pre14a_pluriinc.htm
Using cell science to fight nuclear weapons: How is Pluri revolutionizing health and food tech?
https://www.jpost.com/podcast/inside-israeli-innovation/article-845766
Wow!!! Check Out This February 24th Poster On Pluri's MAIT Cells !!!
Ladies & Gentleman, We Have A Winner !!!
https://pluri-biotech.com/scientific-publications-pluri-health/
Is plant cell culture a scalable way to futureproof cocoa and coffee?
https://agfundernews.com/is-plant-cell-culture-a-scalable-way-to-futureproof-cocoa-and-coffee
IMO...Today's Announcement Makes It Much More Likely, That A United States DoD 12,000 Dose 100 Million Dollar Plus Stock-Piling Deal Is Coming ? Fingers Crossed !!!
https://www.globenewswire.com/news-release/2018/04/30/1489762/0/en/U-S-FDA-Clears-Pluristem-s-IND-to-Treat-Victims-Exposed-to-Acute-Radiation.html
Pluri Announces Exclusive Collaboration Agreement with Hemafund to Enhance Ukraine’s Radiation Emergency Preparedness
https://pluri-biotech.com/releases/pluri-announces-exclusive-collaboration-agreement-with-hemafund-to-enhance-ukraines-radiation-emergency-preparedness/
March Company Presentation !!!
https://pluri-biotech.com/presentation/
Bu¨hler makes new collaboration for cultivated meat
https://www.feedandadditive.com/buhler-makes-new-collaboration-for-cultivated-meat/
Today.....AACR IO 2025 | AACR | Meetings
Chief Scientific Officer Dr. Arthur Machlenkin will be giving a poster session titled “Advancing the allogeneic MAIT platform for targeting solid tumors” on Monday, February 24, 1:45-4pm
Strategic Collaboration for Scalable Cultivated Meat Production
Foodtech innovator Ever After Foods (EAF) and global food leader Bühler have announced a strategic collaboration to accelerate the commercial-scale production of cultivated meat. This partnership aims to provide food producers worldwide with efficient, cost-effective, and scalable cultivated meat production systems, addressing global food security and environmental challenges.
“The global food chain faces significant challenges if we are to successfully and sustainably feed our growing population. Powering cultivated meat production at scale with a patented production system, EAF will help the food industry keep pace with protein demands,” — Ian Roberts, CTO, Bühler
https://igrownews.com/ever-after-foods-latest-news/
Ever After Foods is now working closely with selected cultivated meat companies and food industry leaders to accelerate the development and deployment of its proprietary edible packed-bed (EPB™) technology platform.
https://vegconomist.com/manufacturing-technology/ever-after-foods-buhler-commercial-cultivated-meat-production-system/
Israel’s Ever After Foods has partnered with Swiss manufacturing giant Bühler Group to produce cultivated meat at a mass scale with much smaller equipment.
https://www.greenqueen.com.hk/buhler-ever-after-foods-tnuva-cultivated-meat-bioreactors/
Followers
|
5
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
225
|
Created
|
04/01/24
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |